Predictmedix AI (OTC:PMEDF) Stock, Quote.Headers.trade-ideas

Predictmedix AI Inc provides rapid health screening and remote patient care solutions globally. The company's Safe Entry Stations are powered by a proprietary artificial intelligence (AI) that uses multispectral cameras to analyze physiological data patterns and predict a variety of health issues including infectious diseases such as COVID-19, impairment by drugs or alcohol, fatigue or various mental illnesses.

Cannabis

News

Penny Stocks

SPACE

Entrepreneurship

Eurozone

Health Care

Small Cap

Global

Success Stories

Startups

Small Business

Market-Moving Exclusives

Exclusives

Markets

General

PMEDF

CSE:PMED

Predictmedix Inc. (CSE: PMED) (OTCQB: PMEDF), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI) has received a non-binding Letter of Intent

EXCLUSIVE: Predictmedix Receives $1.85M LOI For 80 Safe Entry Stations From KaTron Defence Space And Simulation Technologies

By Dr. Rahul Kushwah, Interim CEO, Predictmedix

Emerging Technologies Are Advancing The Urgent Need For Noninvasive Cannabis Impairment Detection

Contracts

Tech


	Predictmedix Inc (OTC: PMEDF) has partnered with Entertainment Bay, an event production company in India, to deploy Safe Entry Stations at its client events.


EXCLUSIVE: Predictmedix In Pact With Indian Event Management Firm To Deploy Health Screening Platform

PREDICTMEDIX AI INC by PREDICTMEDIX AI INC.

Predictmedix AI Inc

Battalion Oil Corporation (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BATL#AMEX">BATL</a>) shares are trading higher after the company disclosed an amendment to its Merger Agreement with Fury Resources, Inc., where Fury will acquire all outstanding common stock of <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/g40948402/battalion-oil-corporation-announces-amendment-to-merger-agreement-with-fury-resources-inc" rel="noreferrer noopener">Battalion for $7.00 per share in cash</a>.
In December 2023, Battalion Oil disclosed a merger agreement, under which Fury agreed to acquire all outstanding shares of Battalion&#8217;s common stock for $9.80 per share in cash. The initial deal represented a total transaction <a target="_blank" href="https://www.benzinga.com//node/36256881" rel="noreferrer noopener">value of approximately&nbsp;$450 million.</a>
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, BATL stock has lost over&nbsp;69%&nbsp;in the year-to-date period.
Fury has confirmed capital commitments for the transaction, including $200 million in debt financing from Fortress Credit Corp. and AI Partners Asset Management Co., Ltd., $188 million in Preferred Stock commitments with $173 million from the Rollover Stockholders and $15 million from AI Partners Asset Management Co., Ltd., and $160 million in equity commitments for the acquisition of new common stock in Fury.
The transaction is anticipated to close in the fourth quarter of 2024, pending approval from the Battalion&#8217;s stockholders and satisfaction of other customary closing conditions outlined in the Merger Agreement.
Avi Mirman, Co-Founder and Chairman of Fury Resources, said, &#8220;With this acquisition, Fury has secured a foothold in one of the world&#8217;s most prolific basins. Our team has significant experience in the region, and we believe these assets present a compelling value proposition for our investors.&#8221;
After closing, Fury is expected to hold about $100 million in cash, net of acquisition costs and fees.
Matt Steele, Battalion CEO, said, &#8220;This transaction has taken longer than anyone at the table intended. Despite that, the teams persevered to achieve the best outcome for BATL stockholders. The company and Fury will work diligently in the coming months to close this transaction and position Fury for a successful transition.&#8221;
As of June 30, 2024, the company had $160.2 million in outstanding debt and around <a target="_blank" href="https://www.benzinga.com/pressreleases/24/08/g40379266/battalion-oil-corporation-announces-second-quarter-2024-financial-and-operating-results" rel="noreferrer noopener">$0.3 million in letters of credit</a>.
Price Action: BATL shares are up 120% at $6.47 premarket at the last check Friday.
Image via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/40954292" target="_blank" rel="noreferrer noopener">ConocoPhillips, Uniper Ink 10-Year Gas Supply Deal</a></li>
</ul>

Equities

Movers

BATL

Why Is Battalion Oil Stock Jumping Premarket Friday?

Jefferies analyst Dennis Ding upgrades Assembly Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASMB#NASDAQ">ASMB</a>) from Hold to Buy and raises the price target from $2 to $35.

Upgrades

Price Target

Analyst Ratings

ASMB

Jefferies Upgrades Assembly Biosciences to Buy, Raises Price Target to $35

Offerings

Arq Announces Pricing Of $25M Public Offering Of Common Stock At $5.25 Per Share, Expected To Close September 23, 2024

WIIM

Sable Offshore shares are trading lower after the company announced a $150 million private placement of 7.50 million shares.

Biotech

ADTX

Aditxt's Subsidiary Pearsanta Partners With Evofem Biosciences For Targeted U.S. Launch Of Endometriosis Diagnostic In Mid-2025, Aiming To Be The First Validated Blood-Based Test

VinFast Auto (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFS#NASDAQ">VFS</a>) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0.21) by 57.14 percent. This is a 37.5 percent decrease over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $357.00 million which missed the analyst consensus estimate of $460.09 million by 22.41 percent. This is a 8.84 percent increase over sales of $328.00 million the same period last year.

Earnings

Earnings Misses

VinFast Auto Q2 EPS $(0.33) Misses $(0.21) Estimate, Sales $357.00M Miss $460.09M Estimate

Wedbush analyst Jay McCanless reiterates Lennar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) with a Neutral and maintains $144 price target.

Reiteration

Wedbush Reiterates Neutral on Lennar, Maintains $144 Price Target

Warren Buffett's 2024 strategy is shaking up Wall Street. The Oracle of Omaha isn't sticking to the sidelines and his <a href="https://www.benzinga.com/startups/24/08/40581525/warren-buffetts-quiet-power-move-why-hes-betting-35-billion-on-a-yet-to-be-proven-renewable-energy-s">moves have everyone talking.</a> While Buffett is known for his long-term focus, he's been busy making some significant changes to Berkshire Hathaway's portfolio, both in 2023 and continuing into 2024.&nbsp;
Don't Miss:
<ul>
<li>A billion-dollar investment strategy with minimums as low as $10 —<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> you can become part of the next big real estate boom today.</a></li>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." <a href="https://www.benzinga.com/money/connect-invest-real-estate-notes">These high-yield real estate notes that pay 7.5% &#8211; 9% make earning passive income easier than ever.</a></li>
</ul>
First off, Buffett has sold off his stakes in General Motors and Activision Blizzard. That's right – completely gone. For Activision, it was all about timing. Microsoft's acquisition of the gaming company went through and Buffett saw an opportunity. He had been holding onto Activision as an arbitrage play, waiting for the deal to close. Once it did, Berkshire cashed out, reportedly raking in $1.2 billion.&nbsp;
General Motors? That's a bit more surprising. Buffett had been a longtime supporter of the auto giant but decided to sell off his entire $848 million stake. The auto industry has been hit with challenges from rising interest rates and shifting economic conditions, so it appears Buffett decided it was time to exit.
See Also: General Motors and other leaders revealed to be<a href="https://www.benzinga.com/money/energyx"> investing in this revolutionary lithium start-up — allowing easy entry by launching at just $9.50/share with a $1,000 minimum.</a>
Speaking of opportunities, one of Buffett's more unexpected moves is his investment in the Atlanta Braves. Yes, the baseball team. Berkshire Hathaway bought about $8 million worth of shares in Atlanta Braves Holdings. Sports teams aren't typically Buffett's game, but the Braves have been performing well and sports franchises often have loyal fan bases and steady revenues. In times of market volatility, that kind of stability can be appealing.
But that's not all. In 2024, Buffett has also been buying into Sirius XM Holdings and Liberty Sirius XM Series A/C. Both of these investments are tied to the entertainment sector, signaling Buffett's continued interest in areas that can provide predictable cash flow and growth, even during uncertain market times.
Trending: Groundbreaking trading app with a ‘Buy-Now-Pay-Later' feature for stocks tackles the $644 billion margin lending market –<a href="https://www.benzinga.com/money/wolfpack"> here&#8217;s how to get equity in it with just $500</a>
Also in 2024, Buffett made other notable moves, including a <a href="https://www.benzinga.com/startups/24/08/40464408/is-it-a-sign-warren-buffetts-latest-move-with-apple-stock-is-still-puzzling-investors-but-there-may">reduction in Apple stock – </a>cutting his stake by over 50% while still holding a dominant position. His strategy this year seems to be all about balancing his portfolio between steady performers and fresh opportunities.
So, what's the take-away? Buffett isn't just selling because he's worried about the economy. He's adjusting, looking for value in unexpected places and positioning Berkshire Hathaway for the long haul.
Read Next:
<ul>
<li>Amid the ongoing EV revolution, previously overlooked low-income communities<a href="https://www.benzinga.com/money/dunamis-1"> now harbor a huge investment opportunity at just $500.</a></li>
<li>Elon Musk and Jeff Bezos are bullish on one city that could dethrone New York and become the new financial capital of the US.<a href="https://www.benzinga.com/money/miami-take-new-yorks-place-financial-capital"> Investing in its booming real estate market has never been more accessible.</a></li>
</ul>

Warren Buffett's 2024 Strategy: Selling GM And Activision, Buying Atlanta Braves–Here's Why

Loop Capital analyst Alton Stump maintains Cracker Barrel Old (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBRL#NASDAQ">CBRL</a>) with a Hold and lowers the price target from $50 to $45.

CBRL

Loop Capital Maintains Hold on Cracker Barrel Old, Lowers Price Target to $45

CHWY

Chewy shares are trading lower after the company announced the public offering of shares by a selling stockholder and a concurrent share repurchase.

BNTX

Pfizer And BioNTech Receive Positive CHMP Opinion For Omicron KP.2-Adapted COVID-19 Vaccine In EU, Awaiting European Commission Authorization To Ship

Morgan Stanley analyst Ravi Shanker downgrades FedEx (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) from Equal-Weight to Underweight and lowers the price target from $215 to $200.

Downgrades

Morgan Stanley Downgrades FedEx to Underweight, Lowers Price Target to $200

Ahead of the 2024 presidential election, the front yard of Warren Buffett in Omaha, Nebraska, could play a pivotal role in shaping the outcome.
What Happened: In Nebraska's 2nd Congressional District, a single electoral vote could be crucial. Neighbors are closely watching to see if a blue-dot sign appears outside Buffett's home. These signs, part of a grassroots effort, symbolize Democratic solidarity in a predominantly Republican area, The Wall Street Journal <a href="https://www.wsj.com/us-news/blue-dot-signs-warren-buffett-presidential-race-a9a26579">report</a> on Friday.
Buffett's history of supporting Barack Obama and Hillary Clinton has raised hopes among Democrats. One neighbor even sent Buffett a handwritten letter urging him to display a blue-dot sign. His daughter, Susan Buffett, already has two signs in her yard.
The blue-dot campaign was initiated by Jason Brown, who lives near Buffett. Inspired by the Democratic National Convention, Brown's idea has led to thousands of signs being distributed across Omaha. The signs are especially concentrated in Buffett's upscale neighborhood.
See Also: <a href="https://www.benzinga.com/news/24/09/40950674/data-scientist-who-called-2020-election-correctly-says-its-gone-from-drastic-landslide-in-trumps-dir?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Data Scientist Who Called 2020 Election Correctly Says Its Gone From &#8216;Drastic Landslide In Trump&#8217;s Direction To A drastic landslide For Harris&#8217;</a>
Brown and his wife, Ruth Huebner-Brown, have distributed over 5,000 signs and plan to produce more. They request a $10 contribution to cover costs and pledge to donate any profits. Despite the grassroots effort, Buffett has not commented on whether he will display a sign.
Why It Matters: The influence of Warren Buffett in political circles has been significant over the years. In 2017, Buffett surprisingly <a href="https://www.benzinga.com/markets/equities/24/09/40917216/elon-musk-says-warren-buffett-is-positioning-for-kamala-harris-win-with-his-277b-cash-pile-as-pr">expressed support for Donald Trump'</a>s cabinet choices, indicating his pragmatic approach to politics. This bipartisan stance adds weight to his potential endorsement in the current election.
Recently, Elon Musk speculated that this time, Buffett might be <a href="https://www.benzinga.com/general/politics/17/01/8927406/trumps-newest-unlikely-ally-warren-buffett">positioning for a Kamala Harris win</a>, given his $277 billion cash reserve. This speculation comes amid a divided business community, with hedge fund manager John Paulson warning of a market exit if Harris wins. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/09/40910999/trump-in-trouble-vice-president-harris-has-record-6-point-lead-in-2024-election-poll-after-debat?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump In Trouble: Vice President Harris Has Record 6-Point Lead In 2024 Election Poll After Debate, Posts Highest Rankings In Key Demographics</a></li>
</ul>
Image via Flickr
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Politics

Trump Vs. Harris: Will Warren Buffett Display A Blue Or Red Dot In His Front Yard? Neighbors Wait To See Who The Oracle Of Omaha Is Supporting

The European Medicines Agency&#8217;s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of Novo Nordisk A/S&#8217; (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) Wegovy&nbsp;(semaglutide 2.4 mg) label.
The label <a target="_blank" href="https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=170500" rel="noreferrer noopener">update</a> incorporates data showing that Wegovy, when added to the standard of care, can reduce heart failure-related symptoms and improve physical limitations and exercise function in people with obesity-related HFpEF, with or without type 2 diabetes.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/09/40813963/ozempic-maker-novo-nordisk-touts-encouraging-data-from-new-obesity-pill-showing-double-weight-los" rel="noreferrer noopener">Ozempic Maker Novo Nordisk Touts Encouraging Data From New Obesity Pill Showing Double Weight Loss Compared To Wegovy</a>
Heart failure affects at least 64 million people worldwide and is especially prevalent in obese and/or type 2 diabetes patients.
Heart failure with preserved ejection fraction (HFpEF) is now the most common form of heart failure, comprising approximately 50% of all heart failure cases.
The positive opinion is based on the results from the STEP HFpEF and STEP HFpEF-DM trials.
In both trials, Wegovy&nbsp;demonstrated greater reductions in heart failure-related symptoms, improvements in physical limitations, and weight loss compared to placebo.
The label update also incorporates data that showed that participants receiving Wegovy&nbsp;achieved a greater increase in exercise function, as measured by the difference in 6-minute walking distance (6MWD) from baseline to week 52, compared to those receiving placebo.
The recommendation to incorporate the data from the STEP HFpEF trials adds to the recent Wegovy&nbsp;EMA label update, which included data from the SELECT landmark trial to reflect the risk reduction of heart attack, stroke, and cardiovascular death.
With the positive opinion from the CHMP, Novo Nordisk expects implementation of the EU label update shortly, following a linguistic review process by the EMA.
As communicated earlier this year, Novo Nordisk will resubmit to the FDA in 2025 to include data from the STEP HFpEF trials in the <a target="_blank" href="https://www.benzinga.com/general/biotech/24/08/40229407/novo-nordisk-withdraws-wegovy-fda-heart-failure-submission-terminates-development-of-two-early-st" rel="noreferrer noopener">Wegovy&nbsp;label in the U.S</a>.
In its quarterly earnings report, Novo Nordisk announced that it had submitted the Wegovy STEP HFpEF trials data for regulatory review in the U.S. and EU in January 2024. However, following discussions with the FDA, the company withdrew the submission.
Novo Nordisk said it plans to resubmit the file in early 2025, incorporating additional data, including findings from the kidney outcomes trial for its once-weekly injectable semaglutide 1.0 mg.
Price Action: NVO stock is down 0.42% at $134.32 during the premarket session at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40946305/abbott-laboratories-attractive-valuation-ranks-it-among-top-large-cap-medtech-compa" target="_blank" rel="noreferrer noopener">Abbott Laboratories&#8217; Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst</a>.</li>
</ul>
Photo by Tobias Arhelger via Shutterstock

Large Cap

European Drug Agency Supports Novo Nordisk's Blockbuster Weight-Loss Drug Wegovy For Obesity-Related Heart Failure

Morgan Stanley analyst Dara Mohsenian downgrades PepsiCo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) from Overweight to Equal-Weight and maintains the price target from $185 to $185.

Morgan Stanley Downgrades PepsiCo to Equal-Weight, Maintains Price Target to $185

ATNM

Actinium Pharmaceuticals Publishes Phase 3 SIERRA Trial Results Of Iomab-B In Journal Of Clinical Oncology, Highlights Success In Achieving Complete Remission And Event-Free Survival

Morgan Stanley analyst Rashad Kawan maintains Haleon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLN#NYSE">HLN</a>) with a Overweight and raises the price target from $9.9 to $10.95.

Morgan Stanley Maintains Overweight on Haleon, Raises Price Target to $10.95

Pepe's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>) has been outperforming its dog-themed meme coin rivals, prompting calls for a surge to $10 billion and beyond.
What Happened: Pseudonymous crypto trader SomSpencer declared the arrival of the "meme season" in the crypto market, emphasizing the importance of PEPE as a key indicator. 
He stated that the meme coin has broken out and described Pepe as "the &#8220;meme index" for this crypto cycle, suggesting that its performance is a reliable indicator of the market&#8217;s risk appetite.
The trader <a href="https://x.com/SomSpencer1771/status/1836790093975031916">anticipates</a> PEPE to set new all-time highs in the current quarter, possibly before the election. He also predicts a significant liquidity shift from PEPE as it approaches a $10B billion market cap, with liquidity likely to rotate into midcaps and microcaps.
He concluded by stating, "No one is bullish enough. It&#8217;s time for an up-only market."
Another trader <a href="https://x.com/cryptojourneyrs/status/1836868278943371341">predicts</a> Pepe to overtake Shiba Inu based on Pepe&#8217;s market cap:trading volume ratio.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40876130/dogecoin-millionaire-highlights-pepe-and-dogecoin-as-two-biggest-meme-narratives-for-2025-">&#8216;Dogecoin Millionaire&#8217; Highlights Pepe and Dogecoin As &#8216;Two Biggest Meme Narratives For 2025,&#8217; Shiba Inu, Floki To Follow</a>
Why It Matters: IntoTheBlock data shows a 231.4% increase in large transaction volume and a 33.5% rise in daily active addresses. Transactions greater than $100,000 increased from 80 to 255 in the past two days.
Pepe's seven-day and 30-day gains stand at 13% and 8%, respectively. It has outperformed its rivals Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) and Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>), up 3% and 6% over the past 30 days. In the past seven days, DOGE and SHIB are up 1% and 6%.
Pepe&#8217;s 24-hour trading volume at $1.7 billion exceeds that of both Dogecoin ($741.5 million) and Shiba Inu ($405 million) combined.
What&#8217;s Next: The influence of meme coins is expected to be thoroughly explored at Benzinga&#8217;s upcoming <a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a> event on Nov. 19.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40881260/trader-shares-3-contrarian-takes-trump-meme-coin-an-obvious-buy-and-these-2-cryptos-are-de">Trader Shares &#8216;3 Contrarian Takes:&#8217; TRUMP Meme Coin &#8216;An Obvious Buy&#8217; And These 2 Cryptos Are &#8216;Deep Value&#8217; And Will Be &#8216;Outperforming Soon&#8217;</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$PEPE

$SHIB

Pepe Leapfrogs Dogecoin, Shiba Inu In 30-Day Gains, Trading Volume: 'No One Is Bullish Enough,' Says Trader

CHPT

ChargePoint Says It Has Secured NEVI Award Funding To Proliferate EV Charging On California Highways

Asset Sales

NovaBay Pharmaceuticals Reaches Definitive Deal To Sell Avenova Assets For $9.5M, Expected To Close Q4 2024

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
The revised growth figures for the third quarter <a href="https://www.reuters.com/markets/us/us-third-quarter-economic-growth-revised-up-52-2023-11-29/#:~:text=Gross%20domestic%20product%20increased%20at,the%20fourth%20quarter%20of%202021.">underscore</a> the strong American economy. It records a rapid annualized growth rate of 5.2 percent, the highest since 2014. In stands in stark contrast to the lackluster performance in the U.K. and Europe. President Biden&rsquo;s 2022 Inflation Reduction Act largely accounts for the current strength of the U.S. economy. 



Specifically, the Act primarily consists of a $370 billion clean energy subsidy package over a decade. While intended to be fiscally contractionary over ten years, these subsidies have fueled a boom in high-tech industries. Also, they have played a key role in sustaining business investment growth. 



The stock market has been growing significantly. Hence, these three stocks are the next trillion-dollar stocks that will explode in growth.



<h2>Geo Group (GEO)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/geo-1600-300x169.png" alt="Operated by the for-profit prison company The GEO Group. GEO stock."><div>Source: JosephRouse / Shutterstock</div></div>


Government service provider Geo Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/geo-stock-quote/">GEO</a>) specializes in design and support services for secure facilities and processing centers worldwide.



The <a href="https://finance.yahoo.com/quote/GEO/">stock is up</a> 37.95% to $10.25 in the past year, placing it in an attractive position for investors. And, the global real estate market size was valued at $3.69 trillion in 2021, <a href="https://www.grandviewresearch.com/industry-analysis/real-estate-market#:~:text=The%20global%20real%20estate%20market,5.2%25%20from%202022%20to%202030.">expected</a> to grow at 5.2% CAGR from 2022 to 2030.&nbsp;



Revenue year over year (YOY) <a href="https://finance.yahoo.com/quote/GEO/">increased</a> 5.32% to $2.38 billion, while <a href="https://finance.yahoo.com/quote/GEO/">net income</a> grew 121.93% YOY to $177.81 million. <a href="https://finance.yahoo.com/quote/GEO/">EPS</a> increased by 6.06% to $1.40. Additionally, free cash flow grew to $220.10 million, showing confidence and stability in the financials.



Geo Group&rsquo;s current <a href="https://finance.yahoo.com/quote/GEO/">undervaluation</a> from a 6.4x EBITDA compared to the sector&rsquo;s average of 9.1x, positions it as an investment with deep value. The market is overlooking the company&rsquo;s true potential. Now, investors can benefit from capital appreciation when the company&rsquo;s intrinsic value becomes more widely recognized. Furthermore, the lower 15% short interest, in contrast to competitors with short interests ranging from 25 to 35%, indicates a more positive market sentiment. This reduced short interest not only lowers the risk of a short squeeze but also signals a potential for the stock to outperform in the long term.&nbsp;



Yahoo! Finance <a href="https://finance.yahoo.com/quote/GEO/">analysts</a> label GEO as a buy. The real estate sector shows no signs of slowing down, and GEO is already ahead of the competition through robust financials and under-recognized value.&nbsp;



<h2>Predictmedix AI Inc. (PMEDF)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/healthcare1600b-300x169.jpg" alt="a doctor looks at a tablet. Healthcare stocks to avoid"><div>Source: Shutterstock</div></div>


Predictmedix AI (OTCMKTS:<a href="https://investorplace.com/stock-quotes/pmedf-stock-quote/">PMEDF</a>) is a rapid health screening provider. PMEDF uses multispectral cameras to analyze physiological data patterns and predict health issues like impairment by drugs.



PMEDF stock is up 66.67% year to date (YTD). The biotechnology market was valued at $368 Billion in 2021. And, it <a href="https://www.linkedin.com/pulse/biotechnology-market-anticipated-reach-usd-1334-billion/?trk=article-ssr-frontend-pulse_more-articles_related-content-card">will grow</a> to $1,334 billion by 2030 from a 15.5% CAGR.



Cash from operations YOY <a href="https://finance.yahoo.com/quote/PMED.CN?p=PMED.CN&amp;.tsrc=fin-srch">increased</a> 65.14% to -$534,190, with free cash flow increasing to $167.13K. Clearly, it&rsquo;s showing signs of recovering financials.



Recently, Predictmedix <a href="https://finance.yahoo.com/news/predictmedix-ai-unveils-safe-entry-152000409.html#:~:text=(CSE%3APMED)(OTCQB%3A,D%2D30%20event%20in%20New">introduced</a> its state-of-the-art Safe Entry Stations to delegates from 30 countries at the D-30 event in New Delhi, India. This event signifies a pivotal step forward in the global fight against drug addiction and the disabilities caused by drug abuse. Also, it symbolizes the collaboration of 30 nations recognized by the United Nations for their efforts to address drug addiction worldwide.



Yahoo Finance analysts <a href="https://finance.yahoo.com/quote/PMED.CN?p=PMED.CN&amp;.tsrc=fin-srch">rate</a> PMED as a buy. Thus, this new event primes PMED for long-term growth potential.



<h2>Costco Wholesale (COST)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/03/cost1600-300x169.jpg" alt="A Costco Wholesale (COST) warehouse in Auburn Hills, Michigan."><div>Source: ilzesgimene / Shutterstock.com</div></div>


Costco Wholesale (NASDAQ:<a href="https://investorplace.com/stock-quotes/cost-stock-quote/">COST</a>) is a global retailer with expanded <a href="https://www.costco.com/about.html">operations</a> in 8 countries with hundreds of locations. COST has grown 31.54% YTD.&nbsp;



Retail leader Costco, <a href="https://www.verifiedmarketresearch.com/product/retail-industry-market/">valued</a> at $21.2 trillion in 2022, is forecast to grow to <a href="https://www.verifiedmarketresearch.com/product/retail-industry-market/">$41.3 trillion</a> by 2030 from a 7.69% CAGR. Costco <a href="https://csimarket.com/stocks/competitionSEG2.php?code=COST">holds</a> a 19% market share last quarter compared to competitors.



Financially, Costco performed exceptionally in Q3 of 2023, with $78.9 billion in <a href="https://finance.yahoo.com/quote/COST/financials?p=COST">revenue</a>, growing 9.5% YOY. Also, net income and diluted <a href="https://finance.yahoo.com/quote/COST/financials?p=COST">EPS grew</a> to $2.16 billion and $4.86, which beat industry projections for EPS and revenue by 1%.



The strongest growth catalyst comes from increased sales and revenue attributed to holiday shopping. With Costco&rsquo;s large holiday deals and price cuts, customers are enticed to shop at Costco compared to other competitors. Hence, this stands as a contributing factor to Costco being projected as one of the highest holiday shopping <a href="https://www.thestreet.com/markets/costco-stock-jumps-as-solid-december-sales-allay-spending-concerns">earners</a>. And high revenue will only improve COST stock, giving it an edge to being the next trillion-dollar star.



On the date of publication, Michael Que did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.
<div>Michael Que is a financial writer with extensive experience in the technology industry, with his work featured on Seeking Alpha, Benzinga and MSN Money. He is the owner of Que Capital, a research firm that combines fundamental analysis with ESG factors to pick the best sustainable long-term investments.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/07/venture-capitalist-predicts-this-chatgpt-announcement-will-shock-the-world/?cid=MKT744191&amp;eid=MKT766413">ChatGPT IPO Could Shock the World, Make This Move Before the Announcement</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT766529">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2023/12/the-next-trillion-dollar-stars-3-stocks-to-watch/">The Next Trillion-Dollar Stars: 3 Stocks to Watch</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

The Next Trillion-Dollar Stars: 3 Stocks to Watch

Predictmedix, Inc. (TSE:PMED) has released an update. Predictmedix Inc. has announced strategic partnerships with Samyak Solutions Inc. and Manches...

Predictmedix AI Gears Up for US Expansion

Predictmedix, Inc. (TSE:PMED) has released an update. Predictmedix Inc. is making strides in healthcare innovation with their AI-driven health scre...

Predictmedix AI Innovates Global Healthcare

COST

Press Releases

Predictmedix AI Unveils Safe Entry Stations to Delegates from 30 Nations at D-30 Event in New Delhi

Predictmedix AI Announces Successful Clinical Validation at the University of Raharja, Indonesia, Demonstrating 95% Accuracy in Vital Sign Detection

Predictmedix AI Achieves Significant Milestones in Mental Health Detection and Analysis

Predictmedix AI Elevates Safe Entry Stations with Cutting-Edge Facial Recognition Technology

Predictmedix AI Unveils Technological Advances Including Publishing of Peer-Reviewed Paper

Predictmedix AI and Digital Medical Experts Forge Transformative Alliance in Mental Health

Predictmedix AI Rolls Out Advanced AI-Powered Safe Entry Stations at Trinity Hospital

Predictmedix AI and KGK Science Partner to Enhance Health Research and Product Development

Predictmedix AI and UVTV Digital India Forge Strategic Partnership to Revolutionize Health and Safety in Sports and Worship Venues

Predictmedix AI Expands Reach and Impact in Healthcare Transformation Efforts

Predictmedix AI

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Predictmedix AI

Predictmedix AI (PMEDF) Forecast

Predictmedix AI (OTC:PMEDF) Stock, Quote.Headers.trade-ideas